PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Yasemin, Thoreen, Carson C., Peterson, Timothy R., Lindquist, Robert A., Kang, Seong A., Spooner, Eric, Carr, Steven A., Sabatini, David M.·2007·Molecular Cell
DOI 10.1016/j.molcel.2007.03.003

Cited by (1,000)

Items 601–700 of 1,000

  1. The Regulation of the Autophagic Network and Its Implications for Human Disease
    Jing Hui Yang, Serena Carra, Wei‐Guo Zhu, Harm H. Kampinga · 2013 · International Journal of Biological Sciences
  2. MNK2 Inhibits eIF4G Activation Through a Pathway Involving Serine-Arginine–Rich Protein Kinase in Skeletal Muscle
    Shou‐Ih Hu, Mark Katz, Sherry Chin, Xiaoqing Qi, Joseph M. Cruz, Chikwendu Ibebunjo, Shan-Chuan Zhao, Amy Yen-Chi Chen, David J. Glass · 2012 · Science Signaling
  3. p53 Deletion or Hot-spot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb
    Stuti Agarwal, C. Bell, S. Taylor, R. Moran · 2015 · Molecular Cancer Research
  4. Mechanosensitive Molecular Networks Involved in Transducing Resistance Exercise-Signals into Muscle Protein Accretion
    Emil Rindom, Kristian Vissing · 2016 · Frontiers in Physiology
  5. Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
    Jianya Huan, Petros D. Grivas, Jasmine Birch, Donna Elizabeth Hansel · 2022 · Cancers
  6. Kinase mTOR: Regulation and role in maintenance of cellular homeostasis, tumor development, and aging
    Andrey A. Parkhitko, Olga O. Favorova, Damir Khabibullin, Vladimir Nikolaevich Anisimov, Elizabeth P. Henske · 2014 · Biochemistry (Moscow)
  7. The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas
    Sushma Vemulapalli, Alain C. Mita, Yesid Alvarado, Kamalesh Kumar Sankhala, Monica M Mita · 2011 · Targeted Oncology
  8. The Determinants of Head and Neck Cancer: Unmasking the PI3K Pathway Mutations
    Fernanda S Giudice Cristiane H Squarize · 2013 · Journal of Carcinogenesis & Mutagenesis
  9. Tubers and tumors: rapamycin therapy for benign and malignant tumors
    David R. Plas, George Thomas · 2009 · Current Opinion in Cell Biology
  10. Beyond Genetics: The Role of Metabolism in Photoreceptor Survival, Development and Repair
    Joseph Hanna, Luke Ajay David, Yacine Touahri, Taylor Fleming, Robert A. Screaton, Carol Schuurmans · 2022 · Frontiers in Cell and Developmental Biology
  11. Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study
    A. Gunther, P. Baumann, Renate Burger, Christian Kellner, Wolfram Klapper, Ralf Schmidmaier, Martin Gramatzki · 2015 · Haematologica
  12. mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
    Mio Harachi, Kenta Masui, Yukinori Okamura, Ryota Tsukui, Paul S. Mischel, Noriyuki Shibata · 2018 · International Journal of Molecular Sciences
  13. Lipid-dependent Akt-ivity: where, when, and how
    Katharina M. Siess, Thomas A. Leonard · 2019 · Biochemical Society Transactions
  14. Dynamic remodelling of the human host cell proteome and phosphoproteome upon enterovirus infection
    Piero Giansanti, Jeroen R. P. M. Strating, Kyra A. Y. Defourny, Ieva Cesonyte, Alexia M. S. Bottino, Harm Post, Ekaterina G. Viktorova, Vien Q. T. Ho, Martijn A. Langereis, George A. Belov et al. · 2020 · Nature Communications
  15. Rheb G-Proteins and the Activation of mTORC1
    2010 · The Enzymes
  16. High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy
    Falguni Das, Nirmalya Dey, Balachandar A. Venkatesan, Balakuntalam S. Kasinath, Nandini Ghosh‐Choudhury, Goutam Ghosh Choudhury · 2011 · Cellular Signalling
  17. Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway
    Lei Liu, Long Chen, Yan Luo, Wenxing Chen, Hongyu Zhou, Baoshan Xu, Xiuzhen Han, Tao Shen, Shile Huang · 2010 · PLoS ONE
  18. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy
    A. Gupta, Deepak Sharma, Jairam Meena, Sanketkumar M. Pandya, Madhur Sachan, Sadan Kumar, Kavita Singh, Kalyan Mitra, Sharad C. Sharma, Amulya Kumar Panda et al. · 2016 · Pharmaceutical Research
  19. The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids
    Gerta Hoxhaj, Edward Caddye, Ayaz Najafov, Vanessa P. Houde, Catherine Johnson, Kumara Dissanayake, R. Toth, D. Campbell, A. Prescott, C. MacKintosh · 2016 · eLife
  20. Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
    Ramón Velázquez, Darren M. Shaw, Antonella Caccamo, Salvatore Oddo · 2016 · Molecular Neurodegeneration
  21. Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia
    Maria Rosaria Ricciardi, Simone Mirabilii, Roberto Licchetta, Monica Piedimonte, Agostino Tafuri · 2017 · Advances in Biological Regulation
  22. PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion
    Jiacong Guo, Priyamvada Jayaprakash, Jian Dan, Petra M. Wise, Gyu-Beom Jang, Chengyu Liang, Mei Chen, David T. Woodley, Muller Fabbri, Wei Li · 2017 · Molecular and Cellular Biology
  23. Mammalian Target of Rapamycin
    Matthew F. Wipperman, David C. Montrose, Antonio M. Gotto, David P. Hajjar · 2019 · American Journal Of Pathology
  24. Coordination of Rheb lysosomal membrane interactions with mTORC1 activation
    Brittany Lynn Angarola, Shawn M. Ferguson · 2020 · F1000Research
  25. Iron chelation inhibits mTORC1 signaling involving activation of AMPK and REDD1/Bnip3 pathways
    Chaowei Shang, Hongyu Zhou, Wang Liu, Tao Shen, Yan Luo, Shile Huang · 2020 · Oncogene
  26. Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease
    Naresh K. Meena, E. Ralston, N. Raben, R. Puertollano · 2020 · Molecular Therapy: Methods & Clinical Development
  27. Structural Insights into TOR Signaling
    L. Tafur, Jennifer M. Kefauver, R. Loewith · 2020 · Genes
  28. Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors
    Kristin M. Zimmerman Savill, Brian B. Lee, Jason Oeh, Jie Ming Lin, Eva Lin, Wei‐Jen Chung, Amy E Young, Wennie Chen, Monika Miś, Kathryn Mesh et al. · 2022 · Nature Communications
  29. Effects of contraction and insulin on protein synthesis, AMP-activated protein kinase and phosphorylation state of translation factors in rat skeletal muscle
    Lisa Miranda, Sandrine Horman, Isabelle De Potter, Louis Hue, Jørgen Jensen, Mark H. Rider · 2007 · Pflügers Archiv - European Journal of Physiology
  30. PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40
    Tianhua Zhang, Yuzhen Wang, Hongjiu Yu, Ting Zhang, Lianying Guo, Jie Xu, Xiaoqing Wei, Ning Wang, Yingjie Wu, Xiuli Wang et al. · 2022 · Cell Death and Disease
  31. mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy
    Yuan Gao, Tian Tian · 2023 · International Journal of Molecular Sciences
  32. Oncogenic KRAS signaling activates mTORC1 through COUP‐TFII‐mediated lactate production
    Jun‐Kyu Byun, Mihyang Park, Jae Won Yun, Jaebon Lee, Jae Sun Kim, Sung Jin Cho, You Mie Lee, In‐Kyu Lee, Yeon‐Kyung Choi, Keun‐Gyu Park · 2019 · EMBO Reports
  33. Sensors for the mTORC1 pathway regulated by amino acids
    Xiu-zhi Li, Xianghua Yan · 2019 · Journal of Zhejiang University SCIENCE B
  34. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis
    Rafael Dominik Fritz, Z Varga, Gerald Radziwill · 2010 · Oncogene
  35. Genome-scale RNAi on living-cell microarrays identifies novel regulators ofDrosophila melanogasterTORC1–S6K pathway signaling
    Robert A. Lindquist, Kathleen A. Ottina, Douglas B. Wheeler, Peggy P. Hsu, Carson C. Thoreen, David A. Guertin, Siraj Mahamed Ali, Shomit Sengupta, Yoav David Shaul, Michael R. Lamprecht et al. · 2011 · Genome Research
  36. The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
    Aleksandra Derwich-Rudowicz, Monika Sykutera, Barbara Bromińska, Błażej Rubiś, Marek Ruchała, Nadia Sawicka‐Gutaj · 2023 · International Journal of Molecular Sciences
  37. PRAS40: Target or modulator of mTORC1 signalling and insulin action?
    Emmani B. M. Nascimento, D. Margriet Ouwens · 2009 · Archives of Physiology and Biochemistry
  38. Sepsis-induced changes in amino acid transporters and leucine signaling via mTOR in skeletal muscle
    Lacee Jay Laufenberg, Anne M. Pruznak, Maithili Navaratnarajah, Charles H. Lang · 2014 · Amino Acids
  39. Intestinal Cell Kinase (ICK) Promotes Activation of mTOR Complex 1 (mTORC1) through Phosphorylation of Raptor Thr-908
    Di Wu, Jessica R. Chapman, Lifu Wang, Thurl E. Harris, Jeffrey Shabanowitz, Donald F. Hunt, Zheng Fu · 2012 · Journal of Biological Chemistry
  40. Mammalian target of rapamycin signaling in the podocyte
    Ken Inoki, Tobias Bruno Huber · 2012 · Current Opinion in Nephrology & Hypertension
  41. Sensing the Environment Through Sestrins: Implications for Cellular Metabolism
    Anita Parmigiani, Andrei V. Budanov · 2016 · International review of cytology
  42. Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates
    Luke H. Chao, Joseph Avruch · 2019 · F1000Research
  43. Genomic Alterations in PIK3CA -Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors
    Yanyan Cai, Guotai Xu, Fan Hong Wu, Flavia Michelini, Carmen Chan, Xuan Qu, Pier Selenica, Erik Ladewig, Pau Castel, Yuanming Cheng et al. · 2021 · Cancer Research
  44. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition
    Danni Sun, Hong‐Chun Liu, Xiaoyang Dai, Xingling Zheng, Juan Yan, Rongrui Wei, Xuhong Fu, Min Huang, Aijun Shen, Xun Huang et al. · 2017 · Cancer Letters
  45. The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN
    Lucia Mazzacurati, Robert J. Collins, Garima Pandey, Que T. Lambert-Showers, Narmin E. Amin, Ling Zhang, Matthew C. Stubbs, Pearlie K. Epling‐Burnette, Holly K. Koblish, Gary W. Reuther · 2019 · Blood Advances
  46. The Roles of Post-Translational Modifications on mTOR Signaling
    Shasha Yin, Liu Liu, Wenjian Gan · 2021 · International Journal of Molecular Sciences
  47. Molecular Regulation of Skeletal Muscle Growth and Organelle Biosynthesis: Practical Recommendations for Exercise Training
    Robert Solsona, Laura Pavlin, Henri Bernardi, Anthony M. J. Sanchez · 2021 · International Journal of Molecular Sciences
  48. mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy
    Romina Danesh Pazhooh, Parnia Rahnamay Farnood, Zatollah Asemi, Liaosadat Mirsafaei, Bahman Yousefi, Hamed Mirzaei · 2021 · DNA repair
  49. Recent progress in the discovery of Akt inhibitors as anticancer agents
    Qun Li · 2007 · Expert Opinion on Therapeutic Patents
  50. Caloric restriction effects on liver mTOR signaling are time-of-day dependent
    Tulsian, Richa, Velingkaar, Nikkhil, Kondratov, Roman · 2018 · Aging
  51. Phospho-mTOR: A novel target in regulation of renal lipid metabolism abnormality of diabetes
    Jun Hao, Lin Zhu, Li Fan, Qingjuan Liu, Xue Yan Zhao, Shuxia Liu, Lingling Xing, Xiaojuan Feng, Huijun Duan · 2013 · Experimental Cell Research
  52. PRAS40 Is a Functionally Critical Target for EWS Repression in Ewing Sarcoma
    Lin Huang, Yuji Nakai, Iku Kuwahara, Ken Matsumoto · 2012 · Cancer Research
  53. Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway
    Zhengyu He, Yuxiao Deng, Wen Li, Yongming Chen, Shunpeng Xing, Xianyuan Zhao, Jia Ding, Yuan Gao, Xiangrui Wang · 2014 · Cell & Bioscience
  54. MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells
    Falguni Das, Nirmalya Dey, Amit Bera, Balakuntalam S. Kasinath, Nandini Ghosh‐Choudhury, Goutam Ghosh Choudhury · 2016 · Journal of Biological Chemistry
  55. Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway
    Juanjuan Sun, Xiao-wei Yin, Hui-hui Liu, Wen-xiu Du, Luyao Shi, Yabo Huang, Fen Wang, Chun‐Feng Liu, Yongjun Cao, Yanlin Zhang · 2017 · Acta Pharmacologica Sinica
  56. Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway
    Yuxi Tian, Liangfang Shen, Fujun Li, Junwen Yang, Xiaoping Wan, Miao Ouyang · 2019 · Journal of Cellular Physiology
  57. PRAS40 hyperexpression promotes hepatocarcinogenesis
    Zhaolai Qi, Ting Zhang, Lei Song, Hongyong Fu, Haifeng Luo, Jie Wu, Shuyun Zhao, Tianhua Zhang, Lianying Guo, Lingling Jin et al. · 2020 · EBioMedicine
  58. The Rag GTPase regulates the dynamic behavior of TSC downstream of both amino acid and growth factor restriction
    Shu Yang, Ying-Biao Zhang, Chun-Yuan Ting, L. Bettedi, Kuikwon Kim, Elena Ghaniam, M. Lilly · 2020 · Developmental Cell
  59. mTOR Signaling Components in Tumor Mechanobiology
    Antonios N. Gargalionis, Kostas A. Papavassiliou, Efthimia K. Basdra, Athanasios G. Papavassiliou · 2022 · International Journal of Molecular Sciences
  60. TGFβ-Induced Deptor Suppression Recruits mTORC1 and Not mTORC2 to Enhance Collagen I (α2) Gene Expression
    Falguni Das, Amit Bera, Nandini Ghosh‐Choudhury, Hanna E. Abboud, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2014 · PLoS ONE
  61. Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR
    Robert J. Wagner, Kathleen A. Martin, Richard J. Powell, Eva M. Rzucidlo · 2010 · American Journal of Physiology-Cell Physiology
  62. Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles ofob/obmice
    Andrew M. Miller, Jonathan R. Brestoff, Charles B. Phelps, Eli Zachary Berk, Thomas Reynolds · 2008 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  63. The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma
    Joseph Gera, Alan K. Lichtenstein · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
  64. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts
    Ronald W. Matheny, Martin Louis Adamo · 2009 · Biochemical and Biophysical Research Communications
  65. Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
    Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti, Marialuisa Appetecchia · 2016 · International Journal of Endocrinology
  66. Spatial regulation of the mTORC1 system in amino acids sensing pathway
    Tsukasa Suzuki, Ken Inoki · 2011 · Acta Biochimica et Biophysica Sinica
  67. Loss of hepatic DEPTOR alters the metabolic transition to fasting
    Alexandre Caron, Mathilde Mouchiroud, Nicolas Gautier, Sébastien M. Labbé, Romain Villot, Laurie Turcotte, Blandine Secco, Guillaume Lamoureux, Michaël Shum, Yves Gélinas et al. · 2017 · Molecular Metabolism
  68. Amino acid and small GTPase regulation of mTORC1
    Thu P. Nguyen, Anderson R. Frank, Jenna L. Jewell · 2017 · Cellular Logistics
  69. mTOR Inhibitors in Advanced Biliary Tract Cancers
    Chiao‐En Wu, Ming‐Huang Chen, Chun‐Nan Yeh · 2019 · International Journal of Molecular Sciences
  70. Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia
    N. Murugina, A. S. Budikhina, Yulia A. Dagil, P. Maximchik, L. S. Balyasova, V. Murugin, M. Melnikov, Viktoriya Sharova, A. Nikolaeva, G. Chkadua et al. · 2020 · Journal of Biological Chemistry
  71. Restriction of memory B cell differentiation at the germinal center B cell positive selection stage
    Amparo Toboso-Navasa, Arief Suryono Gunawan, Giulia Morlino, Rinako Nakagawa, Andrea Taddei, Djamil Damry, Yash Patel, Probir Chakravarty, Martin Janz, George Kassiotis et al. · 2020 · The Journal of Experimental Medicine
  72. The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis
    Feng Wu, Zhe Chen, Jingbo Liu, Yu Hou · 2021 · Experimental Hematology
  73. Akt Phosphorylates Both Tsc1 and Tsc2 in Drosophila, but Neither Phosphorylation Is Required for Normal Animal Growth
    Sibylle Schleich, Aurelio A. Teleman · 2009 · PLoS ONE
  74. Autoregulation of the Mechanistic Target of Rapamycin (mTOR) Complex 2 Integrity Is Controlled by an ATP-dependent Mechanism
    Chien-Hung Chen, Vladimir S. Kiyan, Assylbek A. Zhylkibayev, Dubek Kazyken, Olga Bulgakova, Kent E. Page, Rakhmet I. Bersimbaev, Eric Spooner, Dos D. Sarbassov · 2013 · Journal of Biological Chemistry
  75. Genetics and Pharmacology of Longevity
    Jorge Iván Castillo-Quan, Kerri J. Kinghorn, Ivana Bjedov · 2015 · Advances in genetics
  76. Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment
    Xiaoqing Lv, Xiaodong Ma, Yongzhou Hu · 2013 · Expert Opinion on Drug Discovery
  77. The gap junction modifier ZP1609 decreases cardiomyocyte hypercontracture following ischaemia/reperfusion independent from mitochondrial connexin 43
    Kerstin Boengler, Marko Bulic, Rolf Schreckenberg, Klaus‐Dieter Schlüter, Rainer Schulz · 2017 · British Journal of Pharmacology
  78. AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
    Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Ibrahim Damilare Boyenle, Lei Du, Qian Lü, Xiaoxing Yin, Temitope Isaac Adelusi · 2020 · Life Sciences
  79. Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
    Anubhav G. Amin, Seung Eong, John L. Gillick, Tolga Sursal, Raj Murali, Chirag D. Gandhi, Meena Jhanwar‐Uniyal · 2021 · International Journal of Oncology
  80. Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease
    Shaobin Yang, Yaqin Du, Xiaoqian Zhao, Chendong Wu, Peng Yu · 2022 · Cells
  81. Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling
    Brittany L. Jacobs, Rachel M. McNally, Kookjoo Kim, Rocky Blanco, Rachel E. Privett, Jae‐Sung You, Troy Alan Hornberger · 2017 · Journal of Biological Chemistry
  82. The mTORC1/S6K/PDCD4/eIF4A Axis Determines Outcome of Mitotic Arrest
    Moustafa-Kamal, Mohamed, Kucharski, Thomas J., El-Assaad, Wissal, Abbas, Yazan M., Gandin, Valentina, Nagar, Bhushan, Pelletier, Jerry, Topisirovic, Ivan, Teodoro, Jose G. · 2020 · Cell Reports
  83. Nutrient sensing of mTORC1 signaling in cancer and aging
    Cong Jiang, Xiao Tan, Ning Liu, Peiqiang Yan, Tao Hou, Wenyi Wei · 2024 · Seminars in Cancer Biology
  84. The insulin signalling network
    James G. Burchfield, Alexis Díaz‐Vegas, David Ernest James · 2025 · Nature Metabolism
  85. Largen: A Molecular Regulator of Mammalian Cell Size Control
    Kazuo Yamamoto, Valentina Gandin, Masato Sasaki, Susan A. McCracken, Wanda Li, Jennifer Silvester, Andrew Elia, Feng Wang, Yosuke Wakutani, Roumiana Alexandrova et al. · 2014 · Molecular Cell
  86. Transforming Growth Factor β Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy
    Falguni Das, Nandini Ghosh‐Choudhury, Amit Bera, Nirmalya Dey, Hanna E. Abboud, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2013 · Journal of Biological Chemistry
  87. Phosphatidic acid: biosynthesis, pharmacokinetics, mechanisms of action and effect on strength and body composition in resistance-trained individuals
    Peter Bond · 2017 · Nutrition & Metabolism
  88. mTOR and Tumor Cachexia
    A. P. Duval, C. Jeanneret, Tania Santoro, O. Dormond · 2018 · International Journal of Molecular Sciences
  89. Targeting Mammalian Target of Rapamycin: Prospects for the Treatment of Inflammatory Bowel Diseases
    Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Negar Ghanaatian, Parichehr Kohansal, Mohammad Hosein Farzaei, Khashayar Afshari, Amirhossein Sahebkar, Amir Hossein Abdolghaffari · 2020 · Current Medicinal Chemistry
  90. Nuclear Envelope Regulation of Signaling Cascades
    Jason C. Choi, Howard J. Worman · 2014 · Advances in experimental medicine and biology
  91. Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)
    Rosalia Dettori, Silvina V. Sonzogni, Lucas Meyer, Laura A. Lopez-Garcia, Nick A. MORRICE, Stefan Zeuzem, Matthias Engel, Albrecht Piiper, Sonja Neimanis, Morten Frödin et al. · 2009 · Journal of Biological Chemistry
  92. A brief history of TOR
    Robbie Loewith · 2011 · Biochemical Society Transactions
  93. Quantitative phosphoproteomics reveals novel phosphorylation events in insulin signaling regulated by protein phosphatase 1 regulatory subunit 12A
    Xiangmin Zhang, Danjun Ma, Michael A. Caruso, Monique K. Lewis, Yue Andy Qi, Zhengping Yi · 2014 · Journal of Proteomics
  94. mTORC signaling in hematopoiesis
    Xiaomin Wang, Yajing Chu, Weili Wang, Weiping Yuan · 2016 · International Journal of Hematology
  95. Who does TORC2 talk to?
    Jian-Ling Xie, Xue-Min Wang, C. Proud · 2018 · Biochemical Journal
  96. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury
    Dong Liu, Liqun Xu, Xiaoyan Zhang, Changhong Shi, Shubin Qiao, Zhiqiang Ma, Jiansong Yuan · 2018 · Aging and Disease
  97. Signaling Pathways in Leukemic Stem Cells
    Lindsay Meg Gurska, Kristina T. Ames, Kira Gritsman · 2019 · Advances in experimental medicine and biology
  98. mTOR Pathway is Involved in Energy Homeostasis Regulation as a Part of the Gut–Brain Axis
    Verónica Pena-León, Raquel Pérez-Lois, Luisa Maria Seoane · 2020 · International Journal of Molecular Sciences
  99. Targeting PRAS40: a novel therapeutic strategy for human diseases
    Qun Zhou, Shengsong Tang, Xianhui Zhang, Linxi Chen · 2021 · Journal of drug targeting
  100. High‐frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF‐I sensitive signaling pathways
    Sarah Witkowski, Richard M. Lovering, Espen E. Spangenburg · 2010 · FEBS Letters